Net Income Summary of Teyi Pharmaceutical Group Co.,Ltd

Teyi Pharmaceutical Group Co.,Ltd's latest annual net income in 2023 was 253.17 Million CNY , up 42.07% from previous year.
Teyi Pharmaceutical Group Co.,Ltd's latest quarterly net income in 2024 Q2 was -6.46 Million CNY , down -170.62% from previous quarter.
Teyi Pharmaceutical Group Co.,Ltd reported an annual net income of 178.2 Million CNY in 2022, up 40.41% from previous year.
Teyi Pharmaceutical Group Co.,Ltd reported an annual net income of 126.91 Million CNY in 2021, up 189.66% from previous year.
Teyi Pharmaceutical Group Co.,Ltd reported a quarterly net income of -6.46 Million CNY for 2024 Q2, down -170.62% from previous quarter.
Teyi Pharmaceutical Group Co.,Ltd reported a quarterly net income of 9.15 Million CNY for 2024 Q1, down -85.85% from previous quarter.

Annual Net Income Chart of Teyi Pharmaceutical Group Co.,Ltd (2023 - 2009)

Historical Annual Net Income of Teyi Pharmaceutical Group Co.,Ltd (2023 - 2009)

Year	Net Income	Net Income Growth
2023	253.17 Million CNY	42.07%
2022	178.2 Million CNY	40.41%
2021	126.91 Million CNY	189.66%
2020	43.81 Million CNY	-74.48%
2019	171.71 Million CNY	10.39%
2018	155.54 Million CNY	46.27%
2017	106.34 Million CNY	12.2%
2016	94.77 Million CNY	16.86%
2015	81.1 Million CNY	1.14%
2014	80.19 Million CNY	-0.45%
2013	80.55 Million CNY	2.52%
2012	78.57 Million CNY	12.75%
2011	69.69 Million CNY	45.24%
2010	47.98 Million CNY	99.11%
2009	24.09 Million CNY	0.0%

Year	Net Income	Net Income Growth
2024 Q3	3.32 Million CNY	151.36%
2024 Q2	-6.46 Million CNY	-170.62%
2024 Q1	9.15 Million CNY	-85.85%
2023 Q1	105.47 Million CNY	31.12%
2023 Q3	36.35 Million CNY	-22.07%
2023 Q4	64.69 Million CNY	77.94%
2023 FY	253.17 Million CNY	42.07%
2023 Q2	46.65 Million CNY	-55.77%
2022 Q4	80.43 Million CNY	121.57%
2022 Q3	36.3 Million CNY	129.83%
2022 Q2	15.79 Million CNY	-65.41%
2022 FY	178.2 Million CNY	40.41%
2022 Q1	45.66 Million CNY	89.89%
2021 Q2	33.64 Million CNY	-19.26%
2021 Q4	24.04 Million CNY	-12.72%
2021 FY	126.91 Million CNY	189.66%
2021 Q1	41.66 Million CNY	176.96%
2021 Q3	27.55 Million CNY	-18.1%
2020 Q1	22.92 Million CNY	-38.84%
2020 Q2	4.46 Million CNY	-80.51%
2020 FY	43.81 Million CNY	-74.48%
2020 Q3	1.38 Million CNY	-69.08%
2020 Q4	15.04 Million CNY	989.46%
2019 Q1	40.12 Million CNY	17.51%
2019 FY	171.71 Million CNY	10.39%
2019 Q4	37.48 Million CNY	-12.66%
2019 Q3	42.91 Million CNY	-16.16%
2019 Q2	51.18 Million CNY	27.57%
2018 Q1	24.79 Million CNY	-0.66%
2018 FY	155.54 Million CNY	46.27%
2018 Q4	34.14 Million CNY	-25.18%
2018 Q3	45.64 Million CNY	-10.44%
2018 Q2	50.96 Million CNY	105.53%
2017 FY	106.34 Million CNY	12.2%
2017 Q3	27.13 Million CNY	-23.66%
2017 Q4	24.95 Million CNY	-8.0%
2017 Q2	35.53 Million CNY	89.91%
2017 Q1	18.71 Million CNY	-33.87%
2016 Q4	28.3 Million CNY	24.52%
2016 Q3	22.72 Million CNY	-4.51%
2016 Q2	23.79 Million CNY	19.29%
2016 FY	94.77 Million CNY	16.86%
2016 Q1	19.95 Million CNY	6.31%
2015 FY	81.1 Million CNY	1.14%
2015 Q4	18.76 Million CNY	-13.11%
2015 Q3	21.59 Million CNY	7.39%
2015 Q2	20.11 Million CNY	-2.52%
2015 Q1	20.63 Million CNY	30.29%
2014 Q3	17.05 Million CNY	-29.85%
2014 FY	80.19 Million CNY	-0.45%
2014 Q2	24.31 Million CNY	5.79%
2014 Q4	15.83 Million CNY	-7.17%
2014 Q1	22.98 Million CNY	32.64%
2013 Q4	17.32 Million CNY	-16.7%
2013 Q1	22.09 Million CNY	0.0%
2013 Q2	20.32 Million CNY	-7.99%
2013 Q3	20.8 Million CNY	2.34%
2013 FY	80.55 Million CNY	2.52%
2012 FY	78.57 Million CNY	12.75%
2011 FY	69.69 Million CNY	45.24%
2010 FY	47.98 Million CNY	99.11%
2009 FY	24.09 Million CNY	0.0%

Peer Net Income Comparison of Teyi Pharmaceutical Group Co.,Ltd

Name	Net Income	Net Income Difference
Shenzhen Neptunus Bioengineering Co., Ltd.	-1.68 Billion CNY	114.981%
Anhui Fengyuan Pharmaceutical Co., Ltd.	159.28 Million CNY	-58.945%
Dong-E-E-Jiao Co.,Ltd.	1.15 Billion CNY	78.002%
Livzon Pharmaceutical Group Inc.	1.95 Billion CNY	87.041%
Hainan Haiyao Co., Ltd.	-106.48 Million CNY	337.749%
Tus-Pharmaceutical Group Co., Ltd.	25.24 Million CNY	-902.804%
Jilin Aodong Pharmaceutical Group Co., Ltd.	1.45 Billion CNY	82.658%
Changchun High-Tech Industries (Group) Inc.	4.53 Billion CNY	94.414%
Apeloa Pharmaceutical Co.,Ltd	1.05 Billion CNY	76.01%
PKU HealthCare Corp.,Ltd.	44.35 Million CNY	-470.774%
Chengdu Huasun Technology Group Inc., Ltd.	27.65 Million CNY	-815.332%
Dezhan Healthcare Company Limited	83.31 Million CNY	-203.881%
Jinling Pharmaceutical Company Limited	99.65 Million CNY	-154.058%
Jiuzhitang Co., Ltd.	297.41 Million CNY	14.873%
Huapont Life Sciences Co., Ltd.	302.12 Million CNY	16.201%
Zhejiang Jingxin Pharmaceutical Co., Ltd.	618.89 Million CNY	59.092%
Shandong Wohua Pharmaceutical Co., Ltd.	58.76 Million CNY	-330.812%
Hengkang Medical Group Co., Ltd.	30.77 Million CNY	-722.626%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	263.27 Million CNY	3.835%
Qianjiang Yongan Pharmaceutical Co., Ltd.	-12.31 Million CNY	2156.24%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	-783.25 Million CNY	132.323%
Jinhe Biotechnology CO., LTD.	86.45 Million CNY	-192.834%
Kunming Longjin Pharmaceutical Co., Ltd.	-70.94 Million CNY	456.88%
Beijing Aosaikang Pharmaceutical Co., Ltd.	-148.52 Million CNY	270.455%
Chengdu Kanghong Pharmaceutical Group Co., Ltd	1.04 Billion CNY	75.767%
Anhui Huangshan Capsule Co., Ltd.	64.86 Million CNY	-290.321%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd	110.43 Million CNY	-129.259%
Zhuhai Rundu Pharmaceutical Co., Ltd.	66.89 Million CNY	-278.447%
Huaren Pharmaceutical Co., Ltd.	188.06 Million CNY	-34.623%
Tianjin Ringpu Bio-Technology Co.,Ltd.	452.94 Million CNY	44.104%
Shanxi Zhendong Pharmaceutical Co.,Ltd	-43.98 Million CNY	675.607%
Fuan Pharmaceutical (Group) Co., Ltd.	231.86 Million CNY	-9.189%
Hybio Pharmaceutical Co., Ltd.	-513.87 Million CNY	149.268%
Baotou Dongbao Bio-Tech Co.,Ltd	119.88 Million CNY	-111.182%
Hunan Er-Kang Pharmaceutical Co., Ltd	-195.32 Million CNY	229.619%
Changjiang Pharmaceutical Group Co., Ltd.	-605.65 Million CNY	141.802%
Zhejiang Garden Bio-chemical High-tech Co., Ltd.	192.34 Million CNY	-31.623%
Fujian Cosunter Pharmaceutical Co., Ltd.	-348.58 Million CNY	172.629%
Beijing Science Sun Pharmaceutical Co., Ltd.	102.91 Million CNY	-145.998%
Zhejiang Xinguang Pharmaceutical Co., Ltd.	64.35 Million CNY	-293.396%
Hainan Poly Pharm. Co., Ltd	85.92 Million CNY	-194.655%
Jiangxi Synergy Pharmaceutical Co., Ltd.	105.98 Million CNY	-138.883%
Wuhan Hiteck Biological Pharma Co.,Ltd	-120.82 Million CNY	309.543%
Shandong Xinhua Pharmaceutical Company Limited	496.51 Million CNY	49.009%
Zhejiang Tianyu Pharmaceutical Co., Ltd.	27.35 Million CNY	-825.375%
PharmaBlock Sciences (Nanjing), Inc.	197.36 Million CNY	-28.281%
Jinghua Pharmaceutical Group Co., Ltd.	247.69 Million CNY	-2.212%
Zhejiang Hisoar Pharmaceutical Co., Ltd.	-420.05 Million CNY	160.272%
Betta Pharmaceuticals Co., Ltd.	348.03 Million CNY	27.255%
Tibet AIM Pharm. Inc.	15.38 Million CNY	-1545.443%
Shenzhen Kangtai Biological Products Co., Ltd.	861.3 Million CNY	70.606%
Shandong Shanda Wit Science and Technology Co., Ltd.	585.26 Million CNY	56.741%
Pacific Shuanglin Bio-pharmacy Co., LTD	612.11 Million CNY	58.639%
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	138.37 Million CNY	-82.967%
Xiamen Kingdomway Group Company	276.71 Million CNY	8.505%
ShanXi C&Y Pharmaceutical Group Co., Ltd.	25.19 Million CNY	-904.842%
Walvax Biotechnology Co., Ltd.	419.39 Million CNY	39.632%
Sunflower Pharmaceutical Group Co.,Ltd	1.11 Billion CNY	77.378%
Harbin Gloria Pharmaceuticals Co., Ltd	120.33 Million CNY	-110.394%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	2.85 Billion CNY	91.126%
Hunan Hansen Pharmaceutical Co., Ltd.	205.01 Million CNY	-23.491%
Changzhou Qianhong Biopharma CO.,LTD	181.86 Million CNY	-39.214%
Shenzhen Weiguang Biological Products Co., Ltd.	218.65 Million CNY	-15.79%
Honz Pharmaceutical Co., Ltd.	11.52 Million CNY	-2095.827%
Northeast Pharmaceutical Group Co., Ltd.	358.45 Million CNY	29.371%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	43.93 Million CNY	-476.268%
Guizhou Xinbang Pharmaceutical Co., Ltd.	287.23 Million CNY	11.857%
Tianjin Lisheng Pharmaceutical Co.,Ltd.	361.82 Million CNY	30.029%
Zhejiang Yatai Pharmaceutical Co., Ltd.	-11.87 Million CNY	2231.654%
Zhejiang NHU Company Ltd.	2.7 Billion CNY	90.638%
ApicHope Pharmaceutical Co., Ltd	184.61 Million CNY	-37.138%
Shanghai Kaibao Pharmaceutical CO.,Ltd	327.87 Million CNY	22.782%
Beijing SL Pharmaceutical Co., Ltd.	416.69 Million CNY	39.241%
Yunnan Baiyao Group Co.,Ltd	4.09 Billion CNY	93.816%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	61.64 Million CNY	-310.682%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.	161.53 Million CNY	-56.731%
Guangdong Lifestrong Pharmacy Co., Ltd.	33.5 Million CNY	-655.71%
Huadong Medicine Co., Ltd	2.83 Billion CNY	91.082%
Jiangsu Nhwa Pharmaceutical Co., LTD	1.03 Billion CNY	75.584%
Harbin Medisan Pharmaceutical Co., Ltd.	73.66 Million CNY	-243.694%
LanZhou Foci Pharmaceutical Co.,Ltd.	67.18 Million CNY	-276.807%
Tianjin Chase Sun Pharmaceutical Co.,Ltd	506.63 Million CNY	50.028%
Beijing Beilu Pharmaceutical Co., Ltd	-71.75 Million CNY	452.823%
Nanjing Hicin Pharmaceutical Co., Ltd.	36.31 Million CNY	-597.155%
Renhe Pharmacy Co., Ltd.	567.25 Million CNY	55.368%
Chongqing Pharscin Pharmaceutical Co., Ltd.	32.69 Million CNY	-674.258%
Zhejiang Xianju Pharmaceutical Co.,Ltd.	563.08 Million CNY	55.038%
Luoxin Pharmaceuticals Group Stock Co., Ltd.	-661.13 Million CNY	138.294%
Guizhou Bailing Group Pharmaceutical Co., Ltd.	-414.51 Million CNY	161.078%

Global Stocks Search

Teyi Pharmaceutical Group Co.,Ltd (002728.SZ)

Net Income Summary of Teyi Pharmaceutical Group Co.,Ltd

Annual Net Income Chart of Teyi Pharmaceutical Group Co.,Ltd (2023 - 2009)

Historical Annual Net Income of Teyi Pharmaceutical Group Co.,Ltd (2023 - 2009)

Peer Net Income Comparison of Teyi Pharmaceutical Group Co.,Ltd